RESPeRATE - Clinical Studies

Login to your account:

Don't have an account? Create one now! 

Questions? Call us toll-free at 1-888-345-4858

RESPeRATE - Clinical Studies

RESPeRATEA Strong Medical & Scientific Foundation

Guided by a world-renowned Scientific Advisory Board, InterCure, the maker of RESPeRATE, is committed to evidence-based medicine, clinical validation and a sound scientific foundation. The Company has already demonstrated strong clinical validation for RESPeRATE. Clinical achievements for RESPeRATE, the non-drug medical device for lowering blood pressure, include:
The first and only medical device indicated for the adjunctive treatment of hypertension.
14/9 mmHg average sustained blood pressure reductions within 8 weeks.
No side effects, no drug interactions.
Results of six clinical trials were published in peer-reviewed medical journals.

Warranty 1 Year Warranty

Follow these links to learn more:

RESPeRATEhome page
How RESPeRATE Lowers Blood Pressure
RESPeRATE in the news
Frequently Asked Questions
Patient Education Brochure (5 pages)
Clinical Information Brochure (4 pages)

Also See: emWave 6300-SV Personal Stress Reliever

RESPeRATE Reduces Severity of Hypertension
Each point represents the office systolic blood pressure (BP) of the 141 patients in the RESPeRATE treatment group.
Each point represents the office systolic blood pressure (BP) of the 141 patients in the RESPeRATE treatment group.



References:

[1] Schein M, Gavish B, Herz M et al. "Treating hypertension with a device that slows and regularizes breathing: a randomized double-blind controlled study." J Human Hyperten 2001; 15(4): 271 - 278.
[2] Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B "Breathing-control lowers blood pressure." J Human Hyperten 2001; 15(4): 263 - 269.
[3] Rosenthal T, Alter A, Peleg E, Gavish B. "Device-guided breathing exercises reduce blood pressure and ambulatory and home measurement." Am J Hyperten 2001; 14(1): 74 - 76.
[4] Giannattasio C, Failla M, Meles E, Gentile G, Grappiolo A and Mancia G "Efficacy of self treatment of hypertension at home with device-guided breathing." Am J Hyperten 2002; 15(4,2)186A.
[5] Elliott W, Izzo J, Rosing D, Snyder C, White W, Alter A, Gavish B, and Black B "Hypertension reduction by device-guided breathing shows a dose-response relationship." Am J Hyperten 2002; 15(4,2)186A.
RR151 RESPeRATE
Includes the patented RESPeRATE device, a respiration sensor, comfortable headphones, user manual, demonstration video, and four "AA" batteries
QuickMedical Price: $290.00
In Stock
1 Year Warranty 30 Day Return Policy
Add this Medical Supply/Equipment

Shipping Information

Please note: RESPeRATE should only be used as part of your overall health program for achieving goal blood pressure, as recommended by your doctor. RESPeRATE can be safely used in conjunction with medication and lifestyle modification such as diet and exercise.